IGHMBP2 and Charcot-Marie-Tooth disease axonal type 2S: However, Tran and colleagues have recently identified an IGHMBP2 mutation that leads to either SMARD1 or CMT2S, suggesting that the individual genetic background with potential disease-modifying regions plays a critical role in the expression of SMARD1 or CMTS2 [23].